In This Month's Issue

11. Biopharma's Eminent Challenges In 2024 — Inside & Out 12/1/2023

    A baker’s dozen of biopharma CEOs answer a call to prioritize and describe challenges they expect to face in the coming year.

12. Defining A Competitive Next-Gen RNA Therapeutic In 2024 12/1/2023

    To start singling-out where the opportunities exist to craft the next generation of RNA therapeutics, Anna Rose Welch sat down with four RNA executives.

13. Accelerating Drug Development With Real World Data 12/1/2023

    Think real-world data’s only application is clinical trials? Think again. Savvy early-stage biotechs are leveraging RWD in their formative stages, long before entering the clinic, to drive critical efficiencies in drug discovery and development.

14. Top 2024 Clinical Trial Site Challenges: Staffing & Technology 12/1/2023

    Industry experts talk about some of the new challenges facing clinical trial sites in 2024.